Grace Therapeutics (GRCE) Net Equity Issued and Repurchased (2019 - 2022)

Grace Therapeutics (GRCE) posted Net Equity Issued and Repurchased of $109000.0 for Q3 2022, down 44.1% sequentially from $195000.0 in Q2 2022.

Grace Therapeutics (GRCE) Net Equity Issued and Repurchased (2019 - 2022) Analysis & Trends

Grace Therapeutics has reported Net Equity Issued and Repurchased for 4 years, with the latest figure at $109000.0 in Q3 2022.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $109000.0 in Q3 2022, while the trailing twelve-month figure through Jun 2023 was $109000.0 (down 44.1% YoY) and the FY2023 annual result came in at $304000.0, changed N/A from the prior year.
Net Equity Issued and Repurchased eased to $109000.0 in Q3 2022 per GRCE's latest filing, from $195000.0 in the prior quarter.
Over five years, Net Equity Issued and Repurchased peaked at $34.4 million in Q1 2021 and troughed at $109000.0 in Q3 2022.
A 4-year average of $8.3 million and a median of $2.6 million in 2020 frame the typical range for Net Equity Issued and Repurchased.
The sharpest annual moves came in 2020 and 2021: Net Equity Issued and Repurchased soared 228.97% in 2020, then soared 3411.44% in 2021.
Over 4 years, Net Equity Issued and Repurchased stood at $6.0 million in 2019, then jumped by 228.97% to $19.7 million in 2020, then jumped by 74.1% to $34.4 million in 2021, then slumped by 99.68% to $109000.0 in 2022.
According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $109000.0, $195000.0, and $34.4 million for Q3 2022, Q2 2022, and Q1 2021 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	49.20 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Grace Therapeutics	37.99 Mn	37.99 Mn	-	-

Download Data